PHA-680626 - CAS 398493-74-8

PHA-680626 is a potent and selective PLK inhibitor. PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases. PHA-680626 inhibits Plk1 (IC50 = 0.53 μM), Plk2 (IC50 = 0.07 μM) and Plk3 (IC50 = 1.61 μM) .

Bcr-Abl, Aurora Kinase, Apoptosis, c-Myc, Histone Methyltransferase, Others

Cell Cycle/Checkpoint, Others, Chromatin/Epigenetic, Cytoskeletal Signaling, Tyrosine Kinase/Adaptors, Angiogenesis, Apoptosis

398411

C23H26N6O2S

450.56

N(C(=O)C1=CC=C(C=C1)N2CCN(C)CC2)C=3C4=C(CN(C(CC5=CC=CS5)=O)C4)NN3

-20°C

Ice Packs

Small Compound